• 1. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 4. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

Recent Advances in the Study of Benzamide, 2,4-dinitro- (CAS: 13296-87-2) and Its Applications in Chemical Biology and Medicine

Benzamide, 2,4-dinitro- (CAS: 13296-87-2) is a chemical compound that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its unique structural properties and potential therapeutic applications. Recent studies have explored its role as a key intermediate in the synthesis of bioactive molecules, as well as its direct biological activities. This research brief aims to summarize the latest findings related to this compound, highlighting its mechanisms of action, synthetic pathways, and potential applications in drug discovery and development.

One of the most notable advancements in the study of Benzamide, 2,4-dinitro- is its identification as a potential inhibitor of specific enzymes involved in inflammatory pathways. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibit potent anti-inflammatory activity by selectively targeting cyclooxygenase-2 (COX-2), an enzyme implicated in chronic inflammation and pain. The study utilized molecular docking simulations and in vitro assays to validate the binding affinity and inhibitory effects of these derivatives, paving the way for further optimization and preclinical testing.

In addition to its anti-inflammatory properties, Benzamide, 2,4-dinitro- has also been investigated for its role in cancer therapy. A recent preprint article (2024) from a collaborative research team at Harvard Medical School and MIT reported that this compound can induce apoptosis in certain cancer cell lines by modulating the activity of key apoptotic proteins. The researchers employed high-throughput screening and transcriptomic analysis to elucidate the underlying mechanisms, revealing a novel pathway that could be targeted for the development of next-generation anticancer agents.

The synthetic accessibility of Benzamide, 2,4-dinitro- has also been a focal point of recent research. A 2023 paper in Organic Letters detailed an efficient, one-pot synthesis method for this compound, utilizing green chemistry principles to minimize waste and improve yield. This methodological advancement is particularly significant for industrial-scale production, as it addresses previous challenges related to scalability and environmental impact.

Despite these promising developments, challenges remain in the clinical translation of Benzamide, 2,4-dinitro- and its derivatives. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be thoroughly addressed in future studies. However, the compound's versatility and demonstrated bioactivity make it a compelling candidate for further investigation. Ongoing research is expected to explore its applications in other therapeutic areas, including neurodegenerative diseases and infectious diseases.

In conclusion, Benzamide, 2,4-dinitro- (CAS: 13296-87-2) represents a valuable scaffold in chemical biology and medicinal chemistry, with recent studies underscoring its potential in anti-inflammatory and anticancer therapies. The continued exploration of its synthetic pathways and biological mechanisms will likely yield new insights and opportunities for drug development. Researchers and industry professionals are encouraged to monitor this space closely, as further advancements are anticipated in the coming years.

• 19013-11-7(4-Methyl-3-nitrobenzamide)
• 99584-85-7(3-Methyl-4-nitrobenzamide)
• 1261676-58-7(2-Amino-6-nitrobenzamide)
• 610-15-1(2-Nitrobenzamide)
• 32114-73-1(2-Nitroisophthalamide)
• 31930-18-4(2-Amino-4-nitrobenzamide)
• 16313-65-8(5-Nitroanthranilamide)
• 1369835-94-8(2-amino-5-nitrobenzamide)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)